David Arkowitz
2018
In 2018, David Arkowitz earned a total compensation of $3.2M as Chief Financial Officer at Flexion Therapeutics.
Compensation breakdown
| Bonus | $128,000 |
|---|---|
| Option Awards | $1,987,614 |
| Salary | $261,539 |
| Stock Awards | $810,300 |
| Other | $25,448 |
| Total | $3,212,901 |
Arkowitz received $2M in option awards, accounting for 62% of the total pay in 2018.
Arkowitz also received $128K in bonus, $261.5K in salary, $810.3K in stock awards and $25.4K in other compensation.
Rankings
In 2018, David Arkowitz's compensation ranked 3,591st out of 14,244 executives tracked by ExecPay. In other words, Arkowitz earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,591 out of 14,244 | 75th |
Division Manufacturing | 1,326 out of 5,762 | 77th |
Major group Chemicals And Allied Products | 468 out of 2,125 | 78th |
Industry group Drugs | 387 out of 1,814 | 79th |
Industry Pharmaceutical Preparations | 298 out of 1,388 | 79th |
Source: SEC filing on April 26, 2019.
Arkowitz's colleagues
We found four more compensation records of executives who worked with David Arkowitz at Flexion Therapeutics in 2018.